Current Understanding of In-stent Restenosis and the Potential Benefit of Drug Eluting Stents

Publisher： Bentham Science Publishers

E-ISSN： 1875-5895|4|1|103-117

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.4, Iss.1, 2004-03, pp. : 103-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelial Progenitor Cells and In-stent Restenosis

By  

Current Stem Cell Research & Therapy, Vol. 10, Iss. 4, 2015-01 ,pp. : 364-371

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial Progenitor Cells and In-stent Restenosis

By  

Current Stem Cell Research & Therapy, Vol. 10, Iss. 4, 2015-05 ,pp. : 364-371

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Eluting Stents in Interventional Cardiology - Current Evidence and Emerging Uses

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 4, 2005-08 ,pp. : 313-321

Bentham Science Publishers

Access to resources Recommend Favorite

An Update on Clinical and Pharmacological Aspects of Drug-Eluting Stents

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 245-255

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Drug-Eluting Coronary Stents

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 14, Iss. 3, 2014-12 ,pp. : 220-224

Bentham Science Publishers

Access to resources Recommend Favorite